Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
novartis
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alder biopharmaceuticals
alnylam pharmaceuticals
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
beijing
bioeurope
What
medicines
3
×
new
3
×
drug
fda
activity
adds
alliance
amgen
approval
approvals
areas
bio
biogen
biosciences
bio’s
brii
candidates
clamped
class
covid
delays
developed
developing
disease
earlier
economic
fast
gets
head
hepatitis
including
infectious
ipo
isn’t
launched
lot
migraine
million
mission
nod
Language
unset
Current search:
medicines
×
photo
×
new
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines